<a href="https://www.fiercebiotech.com/biotech/odyssey-charts-fresh-voyage-public-markets-after-abandoning-ipo-plans-last-year" hreflang="en">Odyssey charts fresh voyage to public markets after abandoning IPO plans last year</a>
fiercebiotech.com·Apr 20, 2026
Odyssey Therapeutics has announced its plans to go public, indicating a resurgence in the biotech IPO market.
The biotech IPO market is showing signs of revival, as indicated by Odyssey Therapeutics' recent announcement to go public. For someone tracking investment signals in the biotech sector, this could suggest a potential increase in investor confidence and opportunities for funding in innovative biotech ventures.